Jump to content
Comments are closed. Still search and read. Click this red line for lots of support - phone numbers for prostate cancer nurses, psychologist, an advanced man, local groups, depression support, several online and Facebook groups, videos. (JimJimJimJim.com)

Data from a Phase II trial of ARN-509 (apalutamide)

Paul Edwards

By Paul Edwards
in Articles on other sites

Recommended Posts

Paul Edwards Newbie

Paul Edwards

Posted
Posted

"It is clear from these data that apalutamide has activity in the treatment of men with nmCRPC. This is not a surprise. However, the degree of promise for apalutamide based on these data (compared to other drugs already available on the market) is much harder to evaluate. Would treatment of this set of patients with either enzalutamide or abiraterone acetate have shown similar outcomes? We really don’t know."

 

Click on this link to read an article in the New Prostate Cancer Infolink about a recent Phase II trial.

 

 

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing
×
×
  • Create New...